Virtual Event | August 25, 2022

The Importance Of The Starting Materials And Donor Cells

Most cell therapies today are produced from a single patient at a time, using that patient cells as the starting material; yet the one-dose-at-a-time approach can be difficult in a myriad of ways. However, donor cells have their own set of challenges. Blackton and Lee talk through the specific roadblocks for autologous when it comes to both starting materials and allogeneic and donor cells.

access the Virtual Event!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene